Abstract
Recent supply constraints for labetalol, immediate-release nifedipine and misoprostol tablets in Australia have highlighted pregnant women's vulnerability to critical medication supply disruptions, and underscored the broader structural disadvantage this population faces in accessing effective, evidence-based pharmaceutical agents. In this perspective article, we summarise key challenges underpinning this disadvantage and propose some solutions.
| Original language | English |
|---|---|
| Pages (from-to) | 357-359 |
| Number of pages | 3 |
| Journal | Medical Journal of Australia |
| Volume | 221 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - 7 Oct 2024 |
Fingerprint
Dive into the research topics of 'Pharmaceuticals in pregnancy: a multifaceted challenge in Australia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver